SPANO, Maria Carlotta
 Distribuzione geografica
Continente #
NA - Nord America 4.869
EU - Europa 4.231
AS - Asia 2.452
SA - Sud America 352
AF - Africa 57
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.978
Nazione #
US - Stati Uniti d'America 4.764
SE - Svezia 1.972
SG - Singapore 813
IT - Italia 780
CN - Cina 643
GB - Regno Unito 601
VN - Vietnam 288
HK - Hong Kong 283
BR - Brasile 260
DE - Germania 240
RU - Federazione Russa 124
FR - Francia 100
UA - Ucraina 80
FI - Finlandia 79
KR - Corea 68
TR - Turchia 62
IN - India 57
MX - Messico 44
CA - Canada 41
ID - Indonesia 41
BE - Belgio 40
NL - Olanda 39
AR - Argentina 32
BG - Bulgaria 30
BD - Bangladesh 28
JP - Giappone 26
IE - Irlanda 25
ES - Italia 22
PL - Polonia 21
AL - Albania 20
IQ - Iraq 18
ZA - Sudafrica 18
AE - Emirati Arabi Uniti 16
PK - Pakistan 16
EC - Ecuador 15
AU - Australia 14
CL - Cile 12
UZ - Uzbekistan 12
CO - Colombia 11
MY - Malesia 9
VE - Venezuela 9
AT - Austria 8
CZ - Repubblica Ceca 8
JO - Giordania 8
PE - Perù 8
MA - Marocco 7
SA - Arabia Saudita 7
SI - Slovenia 7
PT - Portogallo 6
RO - Romania 6
AZ - Azerbaigian 5
DZ - Algeria 5
PH - Filippine 5
SN - Senegal 5
TN - Tunisia 5
BZ - Belize 4
IL - Israele 4
KE - Kenya 4
KZ - Kazakistan 4
LK - Sri Lanka 4
NP - Nepal 4
OM - Oman 4
BB - Barbados 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
EG - Egitto 3
LB - Libano 3
LT - Lituania 3
MD - Moldavia 3
MN - Mongolia 3
PS - Palestinian Territory 3
RS - Serbia 3
TW - Taiwan 3
BO - Bolivia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
HU - Ungheria 2
IR - Iran 2
JM - Giamaica 2
KH - Cambogia 2
MK - Macedonia 2
PA - Panama 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
Totale 11.961
Città #
Stockholm 1.775
Singapore 548
Ashburn 534
Fairfield 428
Santa Clara 421
Southend 363
Hong Kong 270
Chandler 238
Woodbridge 225
Ann Arbor 221
San Jose 201
Hefei 198
Houston 198
Seattle 180
Wilmington 167
Cambridge 132
Beijing 120
Dearborn 119
Jacksonville 108
Modena 107
Chicago 106
Nyköping 105
Los Angeles 102
London 92
Bologna 91
Ho Chi Minh City 89
Hanoi 86
New York 76
Council Bluffs 75
Munich 64
Seoul 63
Milan 62
The Dalles 54
Helsinki 51
Frankfurt am Main 47
Brussels 37
Lauterbourg 32
Moscow 32
Fremont 31
Izmir 31
Jakarta 31
Shanghai 30
San Diego 29
Orem 26
Sofia 26
Boardman 25
Princeton 25
Dublin 24
Salt Lake City 24
Dallas 23
São Paulo 23
Buffalo 22
Eugene 22
Tampa 21
Parma 19
Rome 19
Elk Grove Village 18
Lancaster 18
Phoenix 18
Bremen 17
Tokyo 17
Reggio Emilia 16
San Giuliano Milanese 16
Columbus 15
Denver 15
Des Moines 15
Falls Church 15
Florence 15
Guangzhou 15
Mexico City 15
Tirana 15
Nuremberg 14
Redwood City 14
Warsaw 14
Amsterdam 13
Chennai 13
Atlanta 12
Da Nang 12
Haiphong 12
Montreal 12
Manchester 11
Brooklyn 10
Genoa 10
Ravenna 10
Redondo Beach 10
Hillsboro 9
Tashkent 9
Adelaide 8
Dulles 8
Johannesburg 8
Ottawa 8
Portsmouth 8
Quito 8
Romola 8
Turku 8
Vienna 8
Amman 7
Baghdad 7
Casalecchio Di Reno 7
Ferrara 7
Totale 8.793
Nome #
A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology. 2.188
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy 457
GD2 expression in breast cancer. 415
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 413
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 403
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 389
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies 384
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing 376
Microglia are less pro-inflammatory than myeloid infiltrates in the hippocampus of mice exposed to status epilepticus 362
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors 357
Mesenchymal progenitors aging highlights a mir-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis 342
Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM 329
Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondria 327
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas 317
Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation 309
Detection of microparticles from human red blood cells by multiparametric flow cytometry 300
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma 287
Donor Cell-Derived Osteopoiesis Originates from a Self-Renewing Stem Cell with a Limited Regenerative Contribution after Transplantation 284
An adoptive immuno-gene therapy approach targeting neuroblastoma. 275
The phenotypes of microglia and macrophages during epileptogenesis 273
Surrounding pancreatic adenocarcinoma by killer mesenchymal stromal/stem cells 272
A 3D Platform to Investigate Dynamic Cell-to-Cell Interactions Between Tumor Cells and Mesenchymal Progenitors 256
Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma 240
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 236
Impact of soluble tumor necrosis factor-related apoptosis-inducing ligand released by engineered adipose mesenchymal stromal cells on white blood cells 233
TRAIL receptors are expressed in both malignant and stromal cells in pancreatic ductal adenocarcinoma 224
Impact of Mesenchymal Stromal/stem Cell Infusions on Circulating Inflammatory Biomarkers in COVID-19 Patients: Analysis of a Phase I-IIa Trial. 203
CELLULE STAMINALI: REALTA’ E PROSPETTIVE 197
Immunotherapy: AUTOLOGOUS ANTI-GD2 CAR T CELLS EFFICIENTLY TARGET PRIMARY HUMAN GLIOBLASTOMA 191
Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma 183
Adoptive CAR T Cell Therapy Targeting GD2-Positive Cancers 179
Una cellula effettrice modificata per il trattamento di neoplasie esprimenti il disialonganglioside GD2 173
CAR-modified killer MSC targeting GD2-positive Ewing sarcoma 164
Abstract A17: Challenging pancreatic ductal adenocarcinoma and its stroma by a combination of chemo and gene therapy: A preclinical study 161
Anti-GD2 chimeric antigen receptor & trail modified mesenchymal progenitors as novel strategy against ewing’s sarcoma 143
Targeting pancreatic ductal adenocarcinoma & its stroma by a chemo & gene therapy strategy 137
5P Anti-GD2 chimeric antigen receptor & TRAIL modified mesenchymal progenitors as novel strategy against Ewing’s sarcoma 120
Totale 12.099
Categoria #
all - tutte 37.290
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.290


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021285 0 0 0 0 0 0 0 0 0 163 92 30
2021/2022777 17 84 101 41 33 31 66 64 66 49 149 76
2022/2023763 100 87 48 90 87 100 12 73 91 7 47 21
2023/2024474 33 26 44 43 76 41 44 60 7 17 21 62
2024/20252.138 51 43 100 167 319 342 225 109 233 100 168 281
2025/20265.289 292 145 299 495 772 195 454 154 2.114 369 0 0
Totale 12.099